Mark Shackleton
Affiliations: | Oncology | Monash University, Melbourne, Australia, Clayton, Victoria, Australia | |
| 2006-2009 | University of Michigan, Ann Arbor, Ann Arbor, MI |
Google:
"Mark Shackleton"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Pacman Szeto | research assistant | 2010- | Monash University, Melbourne, Australia |
| You Fang Zhang | research assistant | 2012- | Monash University, Melbourne, Australia |
| Jen Cheung | research assistant | 2019- | Monash University, Melbourne, Australia |
| Elisha Wybacz | research assistant | 2010-2013 | Peter MacCallum Cancer Centre, Melbourne, Australia |
| Angela Peng | research assistant | 2015-2019 | Monash University, Melbourne, Australia |
| Malaka Ameratinga | grad student | 2018- | Monash University, Melbourne, Australia |
| Samantha Boyle | grad student | 2011-2015 | Peter MacCallum Cancer Centre, Melbourne, Australia |
| Fumihito Noguchi | post-doc | 2016- | Monash University, Melbourne, Australia |
| Gamze Kusur Abali | post-doc | 2018- | Monash University, Melbourne, Australia |
| Bill Tang | post-doc | 2012-2014 | Peter MacCallum Cancer Centre, Melbourne, Australia |
| Clare Fedele | post-doc | 2011-2017 | Peter MacCallum Cancer Centre, Melbourne, Australia |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wu LY, Park SH, Jakobsson H, et al. (2024) Immune Regulation and Immune Therapy in Melanoma: Review with Emphasis on CD155 Signalling. Cancers. 16 |
| Kuser-Abali G, Zhang Y, Szeto P, et al. (2023) UHRF1/UBE2L6/UBR4-mediated ubiquitination regulates EZH2 abundance and thereby melanocytic differentiation phenotypes in melanoma. Oncogene |
| Gangoda L, Schenk RL, Tai L, et al. (2022) Removal of BFL-1 sensitises some melanoma cells to killing by BH3 mimetic drugs. Cell Death & Disease. 13: 301 |
| Vergara IA, Mintoff CP, Sandhu S, et al. (2021) Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling. Nature Communications. 12: 1434 |
| Lynch FA, Katona L, Jefford M, et al. (2020) Feasibility and Acceptability of : A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma. Journal of Clinical Medicine. 9 |
| Samuel E, Lie G, Balasubramanian A, et al. (2020) Impact of Radiotherapy on the Efficacy and Toxicity of anti-PD-1 Inhibitors in Metastatic NSCLC. Clinical Lung Cancer |
| Dall GV, Vieusseux J, Seyed-Razavi Y, et al. (2020) Parity reduces mammary repopulating activity but does not affect mammary stem cells defined as CD24 + CD29/CD49fhi in mice. Breast Cancer Research and Treatment |
| Zhang X, Yang L, Szeto P, et al. (2020) The Hippo pathway oncoprotein YAP promotes melanoma cell invasion and spontaneous metastasis. Oncogene |
| Zhang X, Yang L, Vergara I, et al. (2020) Abstract IA03: The Hippo pathway in melanoma Molecular Cancer Research. 18 |
| Samuel E, Moore M, Voskoboynik M, et al. (2019) An update on adjuvant systemic therapies in melanoma. Melanoma Management. 6: MMT28 |